lontucirev

AXP000033.1 · Oncolytic virus

Platform
adenovirus (Ad2/Ad5 chimera, E1B-55kDa and E3 deleted)
Originator
Onyx Pharmaceuticals

Names

NameTypeSource
lontucirevpreferred name, INNcurator, ncit
CI-1042codencit
ONYX-015codencit
E1B 55kDa mutant adenovirus dl1520synonymncit
dl1520former codepaper

Virus

Role
Oncolytic
Family
Adenoviridae
Virus
human adenovirus 5 (NCBI Taxonomy 28285)
Strain
Ad2/Ad5 chimera (dl1520)
Replication
conditionally replicating
Modifications
E1B-55kDa deleted (nt 2496-3323) plus stop codon at nt 2022; E3 10.4/14.5 and 14.7 deleted
Route
intratumoral, intravenous, intra arterial, intraperitoneal
Source
evidence

Cross-references

NCI Thesaurus
C2830
FDA UNII
F1F4B2ILM1

Approvals

No regulatory approval recorded.

Clinical trials (1)

TrialTitleStatusPhaseStartPrimary completionEnrolmentConditions
NCT00006106ONYX-015 With Cisplatin and Fluorouracil in Treating Patients With Advanced Head and Neck CancerWithdrawnPhase 11999-070Head and Neck Cancer; Lip and Oral Cavity Cancer; Oropharyngeal Cancer

Recent changes

No changes recorded in its trials yet.

Clinical papers

PubMedTitleJournalYearLinked by
PMID 36787278Randomized Cross-Over Study of In-Vehicle Cabin Air Filtration, Air Pollution Exposure, and Acute Changes to Heart Rate Variability, Saliva Cortisol, and Cognitive Function.Environmental science & technology2023name in abstract: CI-1042
PMID 35446353Evaluation of the Durability of the Immune Humoral Response to COVID-19 Vaccines in Patients With Cancer Undergoing Treatment or Who Received a Stem Cell Transplant.JAMA oncology2022name in abstract: CI-1042
PMID 27092831Safety and Immunogenicity of Novel Adenovirus Type 26- and Modified Vaccinia Ankara-Vectored Ebola Vaccines: A Randomized Clinical Trial.JAMA2016name in abstract: CI-1042
PMID 19565928Phase I clinical trial of locoregional administration of the oncolytic adenovirus ONYX-015 in combination with mitomycin-C, doxorubicin, and cisplatin chemotherapy in patients with advanced sarcomas.Methods in molecular biology (Clifton, N.J.)2009name in title: ONYX-015
PMID 17139321Minimal hepatic toxicity of Onyx-015: spatial restriction of coxsackie-adenoviral receptor in normal liver.Cancer gene therapy2007name in title: ONYX-015
PMID 17704755A phase I trial of intravenous infusion of ONYX-015 and enbrel in solid tumor patients.Cancer gene therapy2007name in title: ONYX-015
PMID 15596850Effects of febrile temperature on adenoviral infection and replication: implications for viral therapy of cancer.Journal of virology2005name in abstract: ONYX-015
PMID 15647767Phase I-II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomas.Gene therapy2005name in title: ONYX-015
PMID 15803147Effects of Onyx-015 among metastatic colorectal cancer patients that have failed prior treatment with 5-FU/leucovorin.Cancer gene therapy2005name in title: ONYX-015
PMID 15240522The dl1520 virus is found preferentially in tumor tissue after direct intratumoral injection in oral carcinoma.Clinical cancer research : an official journal of the American Association for Cancer Research2004name in title: dl1520
PMID 15509513A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-Attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant setting.Molecular therapy : the journal of the American Society of Gene Therapy2004name in title: ONYX-015
PMID 12576418A phase I/II trial of intratumoral endoscopic ultrasound injection of ONYX-015 with intravenous gemcitabine in unresectable pancreatic carcinoma.Clinical cancer research : an official journal of the American Association for Cancer Research2003name in title: ONYX-015
PMID 12576437Phase II clinical trial of intralesional administration of the oncolytic adenovirus ONYX-015 in patients with hepatobiliary tumors with correlative p53 studies.Clinical cancer research : an official journal of the American Association for Cancer Research2003name in title: ONYX-015
PMID 12697873Phase II trial of intravenous CI-1042 in patients with metastatic colorectal cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology2003name in title: CI-1042
PMID 12719704Pilot trial of intravenous infusion of a replication-selective adenovirus (ONYX-015) in combination with chemotherapy or IL-2 treatment in refractory cancer patients.Cancer gene therapy2003name in title: ONYX-015
PMID 14597742An attenuated adenovirus, ONYX-015, as mouthwash therapy for premalignant oral dysplasia.Journal of clinical oncology : official journal of the American Society of Clinical Oncology2003name in title: ONYX-015
PMID 11896105Phase I trial of intraperitoneal injection of the E1B-55-kd-gene-deleted adenovirus ONYX-015 (dl1520) given on days 1 through 5 every 3 weeks in patients with recurrent/refractory epithelial ovarian cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology2002name in title: ONYX-015
PMID 11896441Clinical trial of E1B-deleted adenovirus (dl1520) gene therapy for hepatocellular carcinoma.Cancer gene therapy2002name in title: dl1520
PMID 12414631Hepatic arterial infusion of a replication-selective oncolytic adenovirus (dl1520): phase II viral, immunologic, and clinical endpoints.Cancer research2002name in title: dl1520
PMID 11177559E1B-deleted adenovirus (dl1520) gene therapy for patients with primary and secondary liver tumors.Human gene therapy2001name in title: dl1520
PMID 11208818Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology2001name in title: ONYX-015
PMID 11313805Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial.Gene therapy2001name in title: ONYX-015
PMID 11420638Intravenous infusion of a replication-selective adenovirus (ONYX-015) in cancer patients: safety, feasibility and biological activity.Gene therapy2001name in title: ONYX-015
PMID 11895000Intra-arterial administration of a replication-selective adenovirus (dl1520) in patients with colorectal carcinoma metastatic to the liver: a phase I trial.Gene therapy2001name in title: dl1520
PMID 10741699A phase I study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer.Clinical cancer research : an official journal of the American Association for Cancer Research2000name in title: ONYX-015
PMID 10932224a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer.Nature medicine2000name in title: ONYX-015
PMID 11005557A prospective phase II trial of ONYX-015 adenovirus and chemotherapy in recurrent squamous cell carcinoma of the head and neck (the Baylor experience).Annals of surgical oncology2000name in title: ONYX-015
PMID 11103798Selective replication and oncolysis in p53 mutant tumors with ONYX-015, an E1B-55kD gene-deleted adenovirus, in patients with advanced head and neck cancer: a phase II trial.Cancer research2000name in title: ONYX-015
PMID 9717985Advances in the treatment of patients with pancreatic cancer: improvement in symptoms and survival time. The San Antonio Drug Development Team.British journal of cancer1998name in abstract: ONYX-015

Other papers

Preclinical studies, reviews and other papers that name it, newest 100 shown.

PubMedTitleJournalYearLinked by
PMID 41494693Previous tuberculosis modifies spirometry outcomes among small-scale gemstone miners in Tanzania: a cross-sectional, clinic-based study.BMJ open respiratory research2026name in abstract: CI-1042
PMID 42602576The new normal: Simultaneous temporal increases in workload and physician well-being experienced by Stanford pathology in a transformed work environment.Academic pathology2026name in abstract: CI-1042
PMID 42870782Global research trends in oncolytic virotherapy for sarcomas of bone and soft tissue (2000-2024): a bibliometric and visualization study.Translational cancer research2026name in abstract: ONYX-015
PMID 38837373Gene therapy for people with hepatocellular carcinoma.The Cochrane database of systematic reviews2024name in abstract: dl1520
PMID 36299168Oncolytic virus preclinical toxicology studies.Journal of applied toxicology : JAT2023name in abstract: ONYX-015
PMID 37087299Cost-utility of Ranolazine for Chronic Stable Angina Pectoris: Systematic Review and Meta-analysis.Clinical therapeutics2023name in abstract: CI-1042
PMID 37293562Chemoprevention in oral leukoplakia: challenges and current landscape.Frontiers in oral health2023name in abstract: ONYX-015
PMID 38135348Commentary on oncolytic viruses: past, present, and future.Journal for immunotherapy of cancer2023name in abstract: ONYX-015
PMID 35002022Restructuring the ONYX-015 adenovirus by using spike protein genes from SARS-CoV-2 and MERS-CoV: Possible implications in breast cancer treatment.Medical hypotheses2022name in title: ONYX-015
PMID 35596069Ixovex-1, a novel oncolytic E1B-mutated adenovirus.Cancer gene therapy2022name in abstract: ONYX-015
PMID 35756634Role of Adenoviruses in Cancer Therapy.Frontiers in oncology2022name in abstract: ONYX-015
PMID 34155929Optimization of the Administration Strategy for the Armed Oncolytic Adenovirus ZD55-IL-24 in Both Immunocompromised and Immunocompetent Mouse Models.Human gene therapy2021name in abstract: ONYX-015
PMID 32125404Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018.JAMA2020name in abstract: CI-1042
PMID 33257647The armed oncolytic adenovirus ZD55-IL-24 eradicates melanoma by turning the tumor cells from the self-state into the nonself-state besides direct killing.Cell death & disease2020name in abstract: ONYX-015
PMID 30919653Biomarkers of nondipper hypertension in prehypertensive and hypertensive patients.Biomarkers in medicine2019name in abstract: CI-1042
PMID 31933185Current Prospects of Molecular Therapeutics in Head and Neck Squamous Cell Carcinoma.Pharmaceutical medicine2019name in abstract: ONYX-015
PMID 28929492Potent antitumor effect of tumor microenvironment-targeted oncolytic adenovirus against desmoplastic pancreatic cancer.International journal of cancer2018name in abstract: ONYX-015
PMID 29900755Exploring the role of oncolytic viruses in hepatobiliary cancers.Immunotherapy2018name in abstract: dl1520
PMID 28631589Comparison of protein expression during wild-type, and E1B-55k-deletion, adenovirus infection using quantitative time-course proteomics.The Journal of general virology2017name in abstract: dl1520
PMID 26429639Synergistic cytotoxicity against human tumor cell lines by oncolytic adenovirus dl1520 (ONYX-015) and melphalan.Tumori2016name in title: ONYX-015
PMID 27391605Beyond Oncolytics: E1B55K-Deleted Adenovirus as a Vaccine Delivery Vector.PloS one2016name in abstract: ONYX-015
PMID 25376708Virotherapy targeting cyclin E overexpression in tumors with adenovirus-enhanced cancer-selective promoter.Journal of molecular medicine (Berlin, Germany)2015name in abstract: ONYX-015
PMID 25560085Paclitaxel resistance increases oncolytic adenovirus efficacy via upregulated CAR expression and dysfunctional cell cycle control.Molecular oncology2015name in abstract: dl1520
PMID 26280277Going viral: a review of replication-selective oncolytic adenoviruses.Oncotarget2015name in abstract: ONYX-015
PMID 25093639ORCA-010, a novel potency-enhanced oncolytic adenovirus, exerts strong antitumor activity in preclinical models.Human gene therapy2014name in abstract: ONYX-015
PMID 25364261Clinical utility of recombinant adenoviral human p53 gene therapy: current perspectives.OncoTargets and therapy2014name in abstract: ONYX-015
PMID 23596535Tumors and new endoscopic ultrasound-guided therapies.World journal of gastrointestinal endoscopy2013name in abstract: ONYX-015
PMID 24124726Antitumor efficacy of a recombinant adenovirus encoding endostatin combined with an E1B55KD-deficient adenovirus in gastric cancer cells.Journal of translational medicine2013name in abstract: dl1520
PMID 24136729Tumor-specific cytolysis caused by an E1B55K-attenuated adenovirus in nasopharyngeal carcinoma is augmented by cisplatin.Anatomical record (Hoboken, N.J. : 2007)2013name in abstract: dl1520
PMID 22238308Vesicular stomatitis virus as an oncolytic agent against pancreatic ductal adenocarcinoma.Journal of virology2012name in abstract: dl1520
PMID 22321574Targeting Gene-Viro-Therapy with AFP driving Apoptin gene shows potent antitumor effect in hepatocarcinoma.Journal of biomedical science2012name in abstract: ONYX-015
PMID 22880939Oncolytic virotherapy with modified adenoviruses and novel therapeutic targets.Expert opinion on therapeutic targets2012name in abstract: ONYX-015
PMID 23141400[Antitumour efficacy of a novel oncolytic adenovirus Ad-TD-RFP for human nasopharyngeal carcinoma].Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery2012name in abstract: dl1520
PMID 21361787Lister vaccine strain of vaccinia virus armed with the endostatin-angiostatin fusion gene: an oncolytic virus superior to dl1520 (ONYX-015) for human head and neck cancer.Human gene therapy2011name in title: ONYX-015
PMID 21379332A dynamical systems model for combinatorial cancer therapy enhances oncolytic adenovirus efficacy by MEK-inhibition.PLoS computational biology2011name in abstract: ONYX-015
PMID 21818136Deletion analysis of Ad5 E1a transcriptional control region: impact on tumor-selective expression of E1a and E1b.Cancer gene therapy2011name in abstract: ONYX-015
PMID 21836633An oncolytic adenovirus defective in pRb-binding (dl922-947) can efficiently eliminate pancreatic cancer cells and tumors in vivo in combination with 5-FU or gemcitabine.Cancer gene therapy2011name in abstract: dl1520
PMID 21975464The oncolytic adenovirus AdΔΔ enhances selective cancer cell killing in combination with DNA-damaging drugs in pancreatic cancer models.Gene therapy2011name in abstract: ONYX-015
PMID 20165905Dichloroacetate (DCA) enhances tumor cell death in combination with oncolytic adenovirus armed with MDA-7/IL-24.Molecular and cellular biochemistry2010name in abstract: ONYX-015
PMID 20497039Efficacy of oncolytic mutants targeting pRb and p53 pathways is synergistically enhanced when combined with cytotoxic drugs in prostate cancer cells and tumor xenografts.Human gene therapy2010name in abstract: dl1520
PMID 20574150The antitumor efficacy of IL-24 mediated by E1A and E1B triple regulated oncolytic adenovirus.Cancer biology & therapy2010name in abstract: ONYX-015
PMID 20596091A fully replication-competent adenovirus vector with enhanced oncolytic properties.Cancer gene therapy2010name in abstract: ONYX-015
PMID 20598155p21 Promotes oncolytic adenoviral activity in ovarian cancer and is a potential biomarker.Molecular cancer2010name in abstract: ONYX-015
PMID 21103299EUS-Guided Antitumor Therapy for Pancreatic Tumors.Gut and liver2010name in abstract: ONYX-015
PMID 19129452E4orf1 limits the oncolytic potential of the E1B-55K deletion mutant adenovirus.Journal of virology2009name in abstract: ONYX-015
PMID 19407849RNA interference-mediated knockdown of p21(WAF1) enhances anti-tumor cell activity of oncolytic adenoviruses.Cancer gene therapy2009name in abstract: ONYX-015
PMID 19458647In vitro analysis of cidofovir and genetically engineered TK expression as potential approaches for the intervention of ColoAd1-based treatment of cancer.Gene therapy2009name in abstract: ONYX-015
PMID 19481338E1B-55kD-deleted oncolytic adenovirus armed with canstatin gene yields an enhanced anti-tumor efficacy on pancreatic cancer.Cancer letters2009name in abstract: ONYX-015
PMID 19860656Oncolytic adenovirus: preclinical and clinical studies in patients with human malignant gliomas.Current gene therapy2009name in abstract: ONYX-015
PMID 18071311Oncolytic adenoviral mutants induce a novel mode of programmed cell death in ovarian cancer.Oncogene2008name in abstract: ONYX-015
PMID 18300357Telomerase-specific oncolytic virotherapy for human hepatocellular carcinoma.World journal of gastroenterology2008name in abstract: ONYX-015
PMID 18560559Directed evolution generates a novel oncolytic virus for the treatment of colon cancer.PloS one2008name in abstract: ONYX-015
PMID 18618506Significant antitumor activity of oncolytic adenovirus expressing human interferon-beta for hepatocellular carcinoma.The journal of gene medicine2008name in abstract: ONYX-015
PMID 18683102Virus combinations and chemotherapy for the treatment of human cancers.Current opinion in molecular therapeutics2008name in abstract: ONYX-015
PMID 18710328Comparison of molecular strategies for breast cancer virotherapy using oncolytic adenovirus.Human gene therapy2008name in abstract: ONYX-015
PMID 18771358Human telomerase reverse transcriptase promoter-driven oncolytic adenovirus with E1B-19 kDa and E1B-55 kDa gene deletions.Human gene therapy2008name in abstract: ONYX-015
PMID 18927290Bevacizumab increases viral distribution in human anaplastic thyroid carcinoma xenografts and enhances the effects of E1A-defective adenovirus dl922-947.Clinical cancer research : an official journal of the American Association for Cancer Research2008name in abstract: dl1520
PMID 17008933Potent antitumor efficacy of XAF1 delivered by conditionally replicative adenovirus vector via caspase-independent apoptosis.Cancer gene therapy2007name in abstract: ONYX-015
PMID 17079297Adenovirus ubiquitin-protein ligase stimulates viral late mRNA nuclear export.Journal of virology2007name in abstract: dl1520
PMID 17095020Model-driven approaches for in vitro combination therapy using ONYX-015 replicating oncolytic adenovirus.Journal of theoretical biology2007name in title: ONYX-015
PMID 17300834Cancer selective adenoviruses.Molecular aspects of medicine2007name in abstract: ONYX-015
PMID 17346104From ONYX-015 to armed vaccinia viruses: the education and evolution of oncolytic virus development.Current cancer drug targets2007name in title: ONYX-015
PMID 17518613Modification of the Rb-binding domain of replication-competent adenoviral vector enhances cytotoxicity against human esophageal cancers via NF-kappaB activity.Human gene therapy2007name in abstract: ONYX-015
PMID 17577631Synergistic induction of tumor cell death by combining cisplatin with an oncolytic adenovirus carrying TRAIL.Molecular and cellular biochemistry2007name in abstract: ONYX-015
PMID 17690162Lovastatin enhances the replication of the oncolytic adenovirus dl1520 and its antineoplastic activity against anaplastic thyroid carcinoma cells.Endocrinology2007name in title: dl1520
PMID 17965776Rational strain selection and engineering creates a broad-spectrum, systemically effective oncolytic poxvirus, JX-963.The Journal of clinical investigation2007name in abstract: ONYX-015
PMID 18031615Enhanced sensitivity of hepatocellular carcinoma cells to chemotherapy with a Smac-armed oncolytic adenovirus.Acta pharmacologica Sinica2007name in abstract: ONYX-015
PMID 18473990Molecular targeting in pancreatic cancer.Reviews on recent clinical trials2007name in abstract: ONYX-015
PMID 16247442p53 promotes adenoviral replication and increases late viral gene expression.Oncogene2006name in abstract: ONYX-015
PMID 16341141Selective replication of E1B55K-deleted adenoviruses depends on enhanced E1A expression in cancer cells.Cancer gene therapy2006name in abstract: dl1520
PMID 16421637E1A genes of adenovirus type 2 and type 5 are expressed at different levels.Archives of virology2006name in abstract: ONYX-015
PMID 16424034Activity of the adenoviral E1A deletion mutant dl922-947 in ovarian cancer: comparison with E1A wild-type viruses, bioluminescence monitoring, and intraperitoneal delivery in icodextrin.Cancer research2006name in abstract: dl1520
PMID 16467873Targeting gene-virotherapy of cancer.Cell research2006name in abstract: ONYX-015
PMID 16636723Gateways to clinical trials.Methods and findings in experimental and clinical pharmacology2006name in abstract: ONYX-015
PMID 16690321p53 as a target for anti-cancer drug development.Critical reviews in oncology/hematology2006name in abstract: ONYX-015
PMID 16760273Apoptosis: a relevant tool for anticancer therapy.Annals of oncology : official journal of the European Society for Medical Oncology2006name in abstract: ONYX-015
PMID 16969092E1B55K-deleted adenovirus (ONYX-015) overrides G1/S and G2/M checkpoints and causes mitotic catastrophe and endoreduplication in p53-proficient normal cells.Cell cycle (Georgetown, Tex.)2006name in title: ONYX-015
PMID 16971969Adenoviral gene therapy in head and neck cancer.Drug news & perspectives2006name in abstract: ONYX-015
PMID 17102812Targeting gene-virotherapy of cancer and its prosperity.Cell research2006name in abstract: ONYX-015
PMID 17121717[Cytotoxic effect of oncolytic virus combined with mitomycin against human bladder cancer cells in vitro and in vivo].Nan fang yi ke da xue xue bao = Journal of Southern Medical University2006name in abstract: ONYX-015
PMID 17167712Reovirus - possible therapy of cancer.Neoplasma2006name in abstract: ONYX-015
PMID 17171789Antitumor activity of an hTERT promoter-regulated tumor-selective oncolytic adenovirus in human hepatocellular carcinoma.World journal of gastroenterology2006name in abstract: ONYX-015
PMID 15389517Potent antitumor efficacy of an E1B 55kDa-deficient adenovirus carrying murine endostatin in hepatocellular carcinoma.International journal of cancer2005name in abstract: ONYX-015
PMID 15740644Potent antitumoral effects of a novel gene-viral therapeutic system CNHK300-mEndostatin in hepatocellular carcinoma.Chinese medical journal2005name in abstract: ONYX-015
PMID 15762988Heat shock protein 72 expression allows permissive replication of oncolytic adenovirus dl1520 (ONYX-015) in rat glioblastoma cells.Molecular cancer2005name in title: ONYX-015
PMID 15771958Suppression of tumor growth by oncolytic adenovirus-mediated delivery of an antiangiogenic gene, soluble Flt-1.Molecular therapy : the journal of the American Society of Gene Therapy2005name in abstract: ONYX-015
PMID 15814661The dl1520 virus is found preferentially in tumor tissue after direct intratumoral injection in oral carcinoma.Clinical cancer research : an official journal of the American Association for Cancer Research2005name in title: dl1520
PMID 15818382The potential of oncolytic virus therapy for pancreatic cancer.Cancer gene therapy2005name in abstract: ONYX-015
PMID 15854553[hTERT promoter regulated replication-selective adenovirus CNHK300 in treatment of hepatocellular carcinoma].Zhonghua yi xue za zhi2005name in abstract: ONYX-015
PMID 15920462Functional interactions of antiapoptotic proteins and tumor necrosis factor in the context of a replication-competent adenovirus.Gene therapy2005name in abstract: ONYX-015
PMID 15946541[CNHK200-hA-a gene-viral therapeutic system and its antitumor effect on lung cancer].Zhonghua zhong liu za zhi [Chinese journal of oncology]2005name in abstract: ONYX-015
PMID 16000066Potent antitumor activity of oncolytic adenovirus expressing mda-7/IL-24 for colorectal cancer.Human gene therapy2005name in abstract: ONYX-015
PMID 16023599Heat shock phenocopies E1B-55K late functions and selectively sensitizes refractory tumor cells to ONYX-015 oncolytic viral therapy.Cancer cell2005name in title: ONYX-015
PMID 16101516The use of oncolytic vaccinia viruses in the treatment of cancer: a new role for an old ally?Current gene therapy2005name in abstract: ONYX-015
PMID 16155833[Effect of replication- competent adenovirus-mediated interleukin- 12 gene to chemotherapeutic sensitivity on gastric cancer cell].Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery2005name in abstract: ONYX-015
PMID 16299526Viruses - seeking and destroying the tumor program.Oncogene2005name in abstract: ONYX-015
PMID 16555996Cancer scene investigation: how a cold virus became a tumor killer.Future oncology (London, England)2005name in abstract: dl1520
PMID 16556054Elucidation of the molecular mechanism underlying tumor-selective replication of the oncolytic adenovirus mutant ONYX-015.Future oncology (London, England)2005name in title: ONYX-015
PMID 19202637Clinical trials: the sensitizing side of ONYX-015.Gene therapy2005name in title: ONYX-015
PMID 34679293[Insights into a new weapon against cancer: oncolytic viruses].Virologie (Montrouge, France)2005name in abstract: ONYX-015

NIH grants

ProjectTitleOrganisationPIYearsLinked by
R01CA137094Defining Critical p53 Therapeutic Targets and MechanismsSALK INSTITUTE FOR BIOLOGICAL STUDIESO'SHEA, CLODAGH2009–2019name in abstract: ONYX-015
R01CA129975Adenovirus E1B55K Functions Related to Oncolytic ReplicationUNIVERSITY OF LOUISVILLEZHOU, HESHAN SAM2009–2012name in abstract: dl1520
P41RR001614ID OF NOVEL CELLULAR & VIRAL PARTNERS OF THE ADENOVIRUS L4 100K PROTEINUNIVERSITY OF CALIFORNIA, SAN FRANCISCOMCCORMICK, FRANK PATRICK2006–2011name in abstract: ONYX-015
R01CA064799Mechanism of p53 Silencing By Adenovirus E1B 55K ProteinUNIVERSITY OF CALIFORNIA LOS ANGELESBERK, ARNOLD J2007–2011name in abstract: ONYX-015
RC2CA148099Clinical evaluation of a bioadhesive gel for oral cancer chemoprevention.OHIO STATE UNIVERSITYMALLERY, SUSAN R2009–2010name in project terms: ONYX-015
P50CA114747Dual Biotherapy for the Treatment of MalignancySTANFORD UNIVERSITYGAMBHIR, SANJIV S2007–2009name in project terms: ONYX-015
R01CA118545Experimentally Validated Mathematical Modeling of Oncolytic Virus InfectionUNIVERSITY OF CALIFORNIA, SAN FRANCISCOKORN, WOLFGANG MICHAEL2006–2009name in abstract: ONYX-015
R42CA114921Cancer dual-targeting of an infectivity-enhance CRAdVECTORLOGICS, INC.MATHIS, J. MICHAEL2008–2009name in project terms: ONYX-015
R01EY013812Improved Ophthalmic Care for Retinoblastoma PatientsUNIVERSITY OF CALIFORNIA, SAN FRANCISCOO'BRIEN, JOAN M2002–2007name in abstract: ONYX-015
M01RR000079C98-118-01: SCH58500 & chemotherapy in colorectal cancer metastatic to liverUNIVERSITY OF CALIFORNIA, SAN FRANCISCOVENOOK, ALAN PAUL1997–2003name in title: ONYX-015
M01RR001346PHASE I TRIAL OF INTRATUMORAL INJECTION OF ONYX-015 INTO HEAD, NECK TUMORSUNIVERSITY OF TEXAS HLTH SCIENCE CENTERVON HOFF, DANIEL D1998–1999name in title: ONYX-015
R43CA081889ONCOLYTIC HERPES SIMPLEX VIRUS TYPE 1 FOR TUMOR THERAPYONYX PHARMACEUTICALS, INC.LAQUERRE, SYLVIE1999–1999name in abstract: ONYX-015

Notes

First engineered oncolytic virus in human trials (1996). Development as ONYX-015 was stopped by Onyx/Pfizer in 2003; the closely related Chinese construct H101 (AXP000003) was approved instead. INN lontucirev is rarely used; ONYX-015 is the common name.

How to cite

lontucirev (AXP000033.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000033.html

Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.